About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6572 record(s)
Req # A-2023-000528
Adverse Drug Reactions (ADRs) for ARIPIPRAZOLE. Report numbers: E2B_06336965, E2B_06354662, E2B_06356700, E2B_06375857, E2B_06399745, E2B_06402151, E2B_06404345.Organization: Health Canada
October 2023
Req # A-2023-000535
Adverse Drug Reaction (ADR). Report number: E2B_05328556.Organization: Health Canada
October 2023
Req # A-2023-000614
Adverse Drug Reactions (ADRs). Report numbers: E2B_06318317, E2B_06318856, E2B_06331187.Organization: Health Canada
October 2023
Req # A-2023-000624
Adverse Drug Reactions (ADRs). Report numbers: 001041731, E2B_06032298, E2B_04916103, E2B_06343353.Organization: Health Canada
October 2023
Req # A-2023-000625
Adverse Drug Reaction (ADR). Report number: 001042222.Organization: Health Canada
October 2023
Req # A-2023-000629
Adverse Drug Reactions (ADRs) for IXAZOMIB. Report numbers: E2B_06369267, E2B_06363702. ADRs for PANTOLOC. Report numbers: 001041274, 001042681, 001043580. ADRs for PANTOPRAZOLE SODIUM. Report numbers: E2B_06337172, E2B_06386931, E2B_06374715,…Organization: Health Canada
October 2023
Req # A-2023-000648
Adverse Drug Reactions (ADRs). Report numbers: 001034936, 001024752, E2B_06137209, E2B_06200914, E2B_06137218, E2B_05970491, E2B_06137660, E2B_06137610, E2B_02077692, E2B_02840835.Organization: Health Canada
October 2023
Req # A-2023-000659
Adverse Drug Reactions (ADRs). Report numbers: E2B_06186458, E2B_04284263, 001039442, 001030430, E2B_04927216, E2B_06024421, E2B_05377509, 001030547, E2B_04313272, E2B_05969683.Organization: Health Canada
October 2023
Req # A-2023-000661
Adverse Drug Reaction (ADR). Report number: E2B_06252873.Organization: Health Canada
October 2023
Req # A-2023-000669
Adverse Drug Reactions (ADRs). Report numbers: 001049304, E2B_06339717, 001048936, E2B_06396260, E2B_06404235, E2B_06385715, 001042669, E2B_06203117, E2B_06352071, E2B_06295519.Organization: Health Canada
October 2023